New Platelet Membrane Glycoproteins Findings Has Been Reported by Investigators at Bioorganic Chemistry Laboratory (Sialyl Lewis^x Glycomimetics As E- and P-selectin Antagonists Targeting Hyperinflammation).

Researchers at the Bioorganic Chemistry Laboratory in Montreal, Canada, have reported findings on platelet membrane glycoproteins and their role in hyperinflammation. The study highlights the potential of sialyl Lewis(x) glycomimetics as E- and P-selectin antagonists to target systemic inflammatory response syndrome. This research, funded by various organizations including the Canadian Institutes of Health Research, offers promising leads for managing hyperinflammation and immune dysfunction. The study has been peer-reviewed and published in ACS Medicinal Chemistry Letters, providing valuable insights into potential immunomodulators for controlling inflammatory disorders. [Extracted from the article]

Copyright of Medical Letter on the CDC & FDA is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)